Literature DB >> 27526285

Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study.

F Marchesi1, A Tendas2, D Giannarelli3, C Viggiani1, S Gumenyuk1, D Renzi1, L Franceschini4, G Caffarella1, M Rizzo4, F Palombi1, F Pisani1, A Romano1, A Spadea1, E Papa1, M Canfora3, A Pignatelli1, M Cantonetti4, W Arcese4,5, A Mengarelli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27526285     DOI： 10.1038/bmt.2016.207

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Takehiko Mori; Rie Yamazaki; Yoshinobu Aisa; Tomonori Nakazato; Masumi Kudo; Tomoko Yashima; Sakiko Kondo; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Support Care Cancer       Date:  2006-01-28       Impact factor: 3.603

2.  A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.

Authors:  K Lilleby; P Garcia; T Gooley; P McDonnnell; R Taber; L Holmberg; D G Maloney; O W Press; W Bensinger
Journal:  Bone Marrow Transplant       Date:  2006-06       Impact factor: 5.483

3.  Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.

Authors:  Joey Chen; Jamie Seabrook; Adrienne Fulford; Irina Rajakumar
Journal:  J Oncol Pharm Pract       Date:  2016-07-09       Impact factor: 1.809

4.  Prevention of high-dose melphalan-induced mucositis by cryotherapy.

Authors:  Alfredo Tartarone; Rosella Matera; Gianpiero Romano; Maria Luigia Vigliotti; Nicola Di Renzo
Journal:  Leuk Lymphoma       Date:  2005-04

5.  A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients.

Authors:  Prisco Salvador; Cristina Azusano; Lisa Wang; Doris Howell
Journal:  J Pain Symptom Manage       Date:  2012-06-05       Impact factor: 3.612

6.  The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.

Authors:  Linda S Elting; Catherine Cooksley; Mark Chambers; Scott B Cantor; Ellen Manzullo; Edward B Rubenstein
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

7.  Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.

Authors:  Montserrat Vera-Llonch; Gerry Oster; Colleen M Ford; John Lu; Stephen Sonis
Journal:  J Support Oncol       Date:  2007-05

8.  Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.

Authors:  Montserrat Batlle; Mireia Morgades; Susana Vives; Christelle Ferrà; Albert Oriol; Juan-Manuel Sancho; Blanca Xicoy; Miriam Moreno; Laura Magallón; Josep-Maria Ribera
Journal:  Eur J Haematol       Date:  2014-06-21       Impact factor: 2.997

9.  Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.

Authors:  Nicole Blijlevens; Matthias Schwenkglenks; Pamela Bacon; Alessandra D'Addio; Hermann Einsele; Johan Maertens; Dietger Niederwieser; Werner Rabitsch; Ann Roosaar; Tapani Ruutu; Harry Schouten; Rebecca Stone; Samuel Vokurka; Barry Quinn; Shaun McCann
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544

Review 10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860
View more
  5 in total

1.  Oral cryotherapy for management of chemotherapy-induced oral mucositis in haematopoietic cell transplantation: a systematic review.

Authors:  Faizah Jabr Alsulami; Sadr Ul Shaheed
Journal:  BMC Cancer       Date:  2022-04-22       Impact factor: 4.638

2.  Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan.

Authors:  Masaharu Tamaki; Hideki Nakasone; Ayumi Gomyo; Jin Hayakawa; Yu Akahoshi; Naonori Harada; Machiko Kusuda; Yuko Ishihara; Koji Kawamura; Aki Tanihara; Miki Sato; Kiriko Terasako-Saito; Kazuaki Kameda; Hidenori Wada; Misato Kikuchi; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2018-07-23       Impact factor: 2.490

3.  Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines.

Authors:  M Elvira P Correa; Karis Kin Fong Cheng; Karen Chiang; Abhishek Kandwal; Charles L Loprinzi; Takehiko Mori; Carin Potting; Tanya Rouleau; Juan J Toro; Vinisha Ranna; Anusha Vaddi; Douglas E Peterson; Paolo Bossi; Rajesh V Lalla; Sharon Elad
Journal:  Support Care Cancer       Date:  2019-12-14       Impact factor: 3.603

Review 4.  Eficacy of Cryotherapy in the Prevention of Oral Mucosistis in Adult Patients with Chemotherapy.

Authors:  Ángel López-González; Marta García-Quintanilla; Carmen María Guerrero-Agenjo; Jaime López Tendero; Isabel María Guisado-Requena; Joseba Rabanales-Sotos
Journal:  Int J Environ Res Public Health       Date:  2021-01-23       Impact factor: 3.390

5.  The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever.

Authors:  Luis-Gerardo Rodríguez-Lobato; Alexandra Martínez-Roca; Sandra Castaño-Díez; Alicia Palomino-Mosquera; Gonzalo Gutiérrez-García; Alexandra Pedraza; María Suárez-Lledó; Montserrat Rovira; Carmen Martínez; Carlos Fernández de Larrea; María-Teresa Cibeira; Laura Rosiñol; Ester Lozano; Pedro Marín; Joan Cid; Miquel Lozano; Ana Belén Moreno-Castaño; Marta Palomo; Maribel Díaz-Ricart; Cristina Gallego; Adelina Hernando; Susana Segura; Enric Carreras; Álvaro Urbano-Ispizua; Joan Bladé; Francesc Fernández-Avilés
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.